Kane Smith created a new article
2 days ago - Translate

3D Bioprinting Market Regulatory Standards for GMP and Quality Control | #organ-model bioprinting # preclinical tissue screening # patient-specific bioink # vascularized tissue chips # regulatory bioprinting standards # tumor organoid platform # toxicity testing alternatives # pharmaceutical bioprinting integration # preclinical pipeline innovation # personalized drug testing

3D Bioprinting Market Regulatory Standards for GMP and Quality Control

3D Bioprinting Market Regulatory Standards for GMP and Quality Control

The global 3D Bioprinting Market size is expected to be worth around USD 6.9 Billion by 2032 from USD 1.6 billion in 2022, growing at a CAGR of 16.1% during the forecast period from 2022 to 2032.